Halifax, Nova Scotia, 26 August 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received approval from Health Canada for its Reveal® TP (Syphilis) Antibody Test (Reveal® TP) – the fastest standalone screening device for syphilis in Canada. A vital point-of-care tool for healthcare professionals, Reveal® TP is a crucial advancement in expanding access to syphilis testing across Canada—particularly in the Prairie provinces, where rates of infectious and congenital syphilis are surging. The test detects syphilis antibodies from a single finger-prick blood sample, delivering results ...
[ more ]
